The heparin market, valued at USD 7.46 billion in 2024, is anticipated to grow to USD 9.02 billion by 2033, with a CAGR of 2.12% from 2025 to 2033. North America dominates the market with a 36% share in 2024. The market is driven by the growing need for cardiovascular disease treatments, heightened R&D investments, an increase in surgical procedures, and the expanding elderly populati... https://www.imarcgroup.com/heparin-market